EDGAR Filing Documents for 0001072613-17-000281

Form SC 13D - General statement of acquisition of beneficial ownership:

SEC Accession No. 0001072613-17-000281

Filing Date

2017-05-09

Accepted

2017-05-09 15:57:13

Documents

Group Members

ANTHONY A. FLORENCE, JR.DAVID M. MOTTFOREST BASKETTJON M. SAKODAJOSHUA MAKOWERNEA 15 GP, LLCNEA PARTNERS 15, L.P.NEW ENTERPRISE ASSOCIATES 15, L.P.PETER J. BARRISPETER W. SONSINIRAVI VISWANATHANSCOTT D. SANDELL

Document Format Files

Seq	Description	Document	Type	Size
1	VERONA PHARMA PLC -- SCHEDULE 13D	verona-sch13d_18057.htm	SC 13D	403193
	Complete submission text file	0001072613-17-000281.txt		405100

Mailing Address 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093

Business Address 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093 410-842-4000

Growth Equity Opportunities IV, LLC (Filed by) CIK: 0001644965 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE

Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE 011-44-0-2032834200

Verona Pharma plc (Subject) CIK: 0001657312 (see all company filings)